These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Maternal environment and genotype interact to establish diabesity in mice. Reifsnyder PC; Churchill G; Leiter EH Genome Res; 2000 Oct; 10(10):1568-78. PubMed ID: 11042154 [TBL] [Abstract][Full Text] [Related]
3. Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes. Leiter EH; Reifsnyder PC Diabetes; 2004 Feb; 53 Suppl 1():S4-11. PubMed ID: 14749259 [TBL] [Abstract][Full Text] [Related]
4. Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 diabetes. Leiter EH; Reifsnyder PC; Zhang W; Pan HJ; Xiao Q; Mistry J Endocrinology; 2006 Feb; 147(2):919-26. PubMed ID: 16254032 [TBL] [Abstract][Full Text] [Related]
5. 'Fat's chances': Loci for phenotypic dispersion in plasma leptin in mouse models of diabetes mellitus. Perry GML PLoS One; 2019; 14(10):e0222654. PubMed ID: 31661517 [TBL] [Abstract][Full Text] [Related]
6. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background. Garris DR; Garris BL Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481 [TBL] [Abstract][Full Text] [Related]
7. Anti-insulin receptor autoantibodies are not required for type 2 diabetes pathogenesis in NZL/Lt mice, a New Zealand obese (NZO)-derived mouse strain. McInerney MF; Najjar SM; Brickley D; Lutzke M; Abou-Rjaily GA; Reifsnyder P; Haskell BD; Flurkey K; Zhang YJ; Pietropaolo SL; Pietropaolo M; Byers JP; Leiter EH Exp Diabesity Res; 2004; 5(3):177-85. PubMed ID: 15512785 [TBL] [Abstract][Full Text] [Related]
9. Quantitative trait loci for obesity and insulin resistance (Nob1, Nob2) and their interaction with the leptin receptor allele (LeprA720T/T1044I) in New Zealand obese mice. Kluge R; Giesen K; Bahrenberg G; Plum L; Ortlepp JR; Joost HG Diabetologia; 2000 Dec; 43(12):1565-72. PubMed ID: 11151768 [TBL] [Abstract][Full Text] [Related]
10. The genetic basis of obesity and type 2 diabetes: lessons from the new zealand obese mouse, a polygenic model of the metabolic syndrome. Joost HG Results Probl Cell Differ; 2010; 52():1-11. PubMed ID: 20865367 [TBL] [Abstract][Full Text] [Related]
11. Two Novel Candidate Genes for Insulin Secretion Identified by Comparative Genomics of Multiple Backcross Mouse Populations. Schallschmidt T; Lebek S; Altenhofen D; Damen M; Schulte Y; Knebel B; Herwig R; Rasche A; Stermann T; Kamitz A; Hallahan N; Jähnert M; Vogel H; Schürmann A; Chadt A; Al-Hasani H Genetics; 2018 Dec; 210(4):1527-1542. PubMed ID: 30341086 [TBL] [Abstract][Full Text] [Related]
12. Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse. Igel M; Becker W; Herberg L; Joost HG Endocrinology; 1997 Oct; 138(10):4234-9. PubMed ID: 9322935 [TBL] [Abstract][Full Text] [Related]
13. Type 2 diabetes-like hyperglycemia in a backcross model of NZO and SJL mice: characterization of a susceptibility locus on chromosome 4 and its relation with obesity. Plum L; Kluge R; Giesen K; Altmüller J; Ortlepp JR; Joost HG Diabetes; 2000 Sep; 49(9):1590-6. PubMed ID: 10969845 [TBL] [Abstract][Full Text] [Related]
14. Characterisation of the mouse diabetes susceptibilty locus Nidd/SJL: islet cell destruction, interaction with the obesity QTL Nob1, and effect of dietary fat. Plum L; Giesen K; Kluge R; Junger E; Linnartz K; Schürmann A; Becker W; Joost HG Diabetologia; 2002 Jun; 45(6):823-30. PubMed ID: 12107726 [TBL] [Abstract][Full Text] [Related]
15. Positional cloning of zinc finger domain transcription factor Zfp69, a candidate gene for obesity-associated diabetes contributed by mouse locus Nidd/SJL. Scherneck S; Nestler M; Vogel H; Blüher M; Block MD; Berriel Diaz M; Herzig S; Schulz N; Teichert M; Tischer S; Al-Hasani H; Kluge R; Schürmann A; Joost HG PLoS Genet; 2009 Jul; 5(7):e1000541. PubMed ID: 19578398 [TBL] [Abstract][Full Text] [Related]
17. NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds. Leiter EH; Reifsnyder PC; Flurkey K; Partke HJ; Junger E; Herberg L Diabetes; 1998 Aug; 47(8):1287-95. PubMed ID: 9703330 [TBL] [Abstract][Full Text] [Related]
18. OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. Wang MY; Koyama K; Shimabukuro M; Newgard CB; Unger RH Proc Natl Acad Sci U S A; 1998 Jan; 95(2):714-8. PubMed ID: 9435258 [TBL] [Abstract][Full Text] [Related]
19. Single diabetic QTL derived from OLETF rat is a sufficient agent for severe diabetic phenotype in combination with leptin-signaling deficiency. Kose H; Yamada T; Matsumoto K Exp Diabetes Res; 2012; 2012():858121. PubMed ID: 23304119 [TBL] [Abstract][Full Text] [Related]
20. Contrasting obesity phenotypes uncovered by partial leptin receptor gene deletion in transgenic mice. Reichart U; Renner-Müller I; Höflich A; Müller OJ; Franz WM; Wolf E; Müller M; Brem G; Aigner B Biochem Biophys Res Commun; 2000 Mar; 269(2):502-7. PubMed ID: 10708583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]